Alterations should be manufactured cautiously plus the frequency of blood glucose monitoring should be amplified. Adjustments in concomitant oral antidiabetic treatment may be desired.Transient SAFETY STATEMENT: Failure to utilize the Dexcom Continual Glucose Monitoring Procedure and its components in accordance with the Guidelines for use provide